Skip to main content

NASDAQ:XERS Shareholder Notice: Investigation over Possible Securities Laws Violations by Xeris Pharmaceuticals, Inc.

San Diego, CA -- (SBWIRE) -- 03/22/2021 -- Xeris Pharmaceuticals, Inc. is under investigation concerning potential violations of securities laws in connection with certain financial statements.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.